Medpace Holdings (MEDP) EBT (2015 - 2026)

Medpace Holdings has reported EBT for 12 years, with the latest figure at $147.6 million in Q1 2026.

• For the quarter ending Q1 2026, EBT rose 24.9% year-over-year to $147.6 million; the trailing twelve-month figure through Mar 2026 stood at $571.8 million (up 18.8% YoY), and the FY2025 full-year result was $542.4 million, up 13.96% from the prior year.
• EBT for Q1 2026 stood at $147.6 million, down from $156.8 million in the prior quarter.
• The five-year high for EBT was $156.8 million in Q4 2025, with the low at $62.0 million in Q2 2022.
• Historically, EBT has averaged $105.0 million across 5 years, with a median of $110.5 million in 2024.
• Annual changes were most pronounced in 2022 — EBT surged 49.61% — and 2023, when it climbed 1.6%.
• Medpace Holdings' EBT stood at $73.6 million in 2022, then increased by 23.17% to $90.7 million in 2023, then jumped by 47.6% to $133.9 million in 2024, then gained by 17.14% to $156.8 million in 2025, then declined by 5.89% to $147.6 million in 2026.
• The last three EBT figures came in at $147.6 million (Q1 2026), $156.8 million (Q4 2025), and $142.8 million (Q3 2025), per Business Quant data.